Category: General Pharmaceutical Council (GPhC)
GPhC to publish transparent disqualification policy in 2026
GPhC has confirmed it is developing a “clear and transparent” policy on the disqualification of pharmacy owners, with plans to publish the framework in summer 2026.
Read More
NHS staff face fitness to practise risks over Gaza commentary, say campaigners
NHS healthcare professionals are voicing concern over alleged institutional bias and harsh disciplinary measures for expressing views on Gaza.
Read More
FEATURE: Assessing insight when a registrant denies allegations in fitness to practise proceedings
Fitness to practise defence barristers, Kings View Medical, looks at insight in circumstances when a registrant denies allegations.
Read More
GPHC sets standards for reflective account set for 2026
From January 2026, pharmacy professionals can reflect against any of the nine GPhC standards for their revalidation reflective account.
Read More
GPhC faces scrutiny over fitness to practise delays and upheld complaints
GPhC’s 2024/25 annual report revealed a 25% increase in the time taken to resolve fitness to practise cases.
Read More
PSA updates right-touch regulation framework to address modern challenges in fitness to practise
PSA has released the 2025 edition of its Right-touch regulation framework, offering updated guidance for health and social care regulators.
Read More
GPhC review flags regulatory gaps in pharmacies supplying medicinal cannabis
GPhC has published a themed review of pharmacies involved in the supply of cannabis-based products for medicinal use.
Read More
Concerns over weight-loss jabs prompt nearly 750 GPhC fitness to practise referrals
GPhC has received nearly 750 concerns in 2025 related to the supply of weight-loss injections, including semaglutide and liraglutide.
Read More
GPhC consultation aims to embed fitness to practise in technician training
GPhC has launched a 12-week consultation on new draft standards for the initial education and training of pharmacy technicians.
Read More
Whistleblower disclosures to GPhC surge, highlighting fitness to practise risks
Whistleblower disclosures to the General Pharmaceutical Council (GPhC) jumped by 208 percent over the past year.
Read More
GPhC issues enforcement notice on weight-loss medicine advertising
GPhC issues enforcement notice on weight-loss medicine advertising to protect public and uphold fitness to practise.
Read More
PSA flags delays in GPhC fitness to practise investigations in annual performance review
PSA has published its annual performance review of the GPhC, identifying delays in fitness to practise investigations.
Read More
Kings View Chambers
Recent Comments